Evidence map›Paper›PMID 26494981›Full record

ReviewArchaea (Vancouver, B.C.)2015

Archaeal Enzymes and Applications in Industrial Biocatalysts.

Jennifer A Littlechild

Abstract readReview
In one paragraph

Review in Archaea (Vancouver, B.C.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Predicting Functional Diversity Within Enzyme Families: A Practical Perspective.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Article
  3. Article
  4. Biotechnological Applications of Archaea.Progress in molecular and subcellular biology · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Extremophiles in a changing world.Extremophiles : life under extreme conditions · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. A Novel L-Asparaginase from Hyperthermophilic ArchaeonInternational journal of molecular sciences · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jennifer A LittlechildHenry Wellcome Building for Biocatalysis, Biosciences, College of Life and Environmental Sciences, Stocker Road, Exeter EX4 4QD, UK.

Funding

Biotechnology and Biological Sciences Research Council BB/LOO2035/1Wellcome Trust
6 · The paper itself

Abstract

Archaeal enzymes are playing an important role in industrial biotechnology. Many representatives of organisms living in "extreme" conditions, the so-called Extremophiles, belong to the archaeal kingdom of life. This paper will review studies carried by the Exeter group and others regarding archaeal enzymes that have important applications in commercial biocatalysis. Some of these biocatalysts are already being used in large scale industrial processes for the production of optically pure drug intermediates and amino acids and their analogues. Other enzymes have been characterised at laboratory scale regarding their substrate specificity and properties for potential industrial application. The increasing availability of DNA sequences from new archaeal species and metagenomes will provide a continuing resource to identify new enzymes of commercial interest using both bioinformatics and screening approaches.

Indexed as

ArchaeaBiotechnologyComputational BiologyEnzymesGenomicsSubstrate SpecificityTechnology, PharmaceuticalEnzymes

Identifiers

PMID26494981
PMCPMC4606452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.